[1] Costerton, J., Lewandowski, Z., Caldwell, D., Korber, D. and Lappin-Scott, H. (1995) Microbial Biofilms. Annual Review of Microbiology, 49, 711-745.
http://dx.doi.org/10.1146/annurev.mi.49.100195.003431
[2] Costerton, J.W., Stewart, P.S. and Greenberg, E.P. (1999) Bacterial Biofilms: A Common Cause of Persistent Infections. Science, 284, 1318-1322.
http://dx.doi.org/10.1126/science.284.5418.1318
[3] Gilbert, P., Maira-Litran, T., McBain, A., Rickard, A. and Whyte, F. (2002) The Physiology and Collective Recalcitrance of Microbial Biofilm Communities. Advances in Microbial Physiology, 46, 202-256.
http://dx.doi.org/10.1016/S0065-2911(02)46005-5
[4] Dongari-Bagtzoglou, A. (2008) Pathogenesis of Mucosal Biofilm Infections: Challenges and Progress. Expert Review of Anti-Infective Therapy, 6, 201-208.
http://dx.doi.org/10.1586/14787210.6.2.201
[5] Lewis, K. (2001) Riddle of Biofilm Resistance. Antimicrob Agents Chemother, 45, 999-1007.
http://dx.doi.org/10.1128/AAC.45.4.999-1007.2001
[6] Wise, R., Hart, T., Cars, O., Streulens, M., Helmuth, R., Huovinen, P. and Sprenger, M. (1998) Antimicrobial Resistance. BMJ, 317, 609-610.
http://dx.doi.org/10.1136/bmj.317.7159.609
[7] Farzam, F. and Plotkin, B.J. (2001) Effect of Sub-MICs of Antibiotics on the Hydrophobicity and Production of Acidic Polysaccharide by Vibrio vulnificus. Chemotherapy, 47, 184-193.
http://dx.doi.org/10.1159/000063220
[8] Pinheiro, L., Brito, C.I., Pereira, V.C., de Oliveira, A., Camargo, C.H. and da Cunha, M. (2014) Reduced Susceptibility to Vancomycin and Biofilm Formation in Methicillin-Resistant Staphylococcus epidermidis Isolated from Blood Cultures. Memórias do Instituto Oswaldo Cruz, 109, 871-878.
http://dx.doi.org/10.1590/0074-0276140120
[9] Wojnicz, D. (2007) The Influence of Subinhibitory Concentrations of Antibiotics on the Bacterial Adhesion. Advances in Clinical and Experimental Medicine, 16, 141-148.
[10] Lau, D. and Plotkin, B. (2013) Antimicrobial and Biofilm Effects of Herbs Used in Traditional Chinese Medicine. Natural Product Communications, 8, 1617-1620.
[11] Borriello, G., Werner, E., Roe, F., Kim, A., Ehrlich, G. and Stewart, P. (2004) Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms. Antimicrobial Agents and Chemotherapy, 48, 2659-2664.
http://dx.doi.org/10.1128/AAC.48.7.2659-2664.2004
[12] Murphy, T. and Parameswaran, G. (2009) Moraxella catarrhalis, a Human Respiratory Tract Pathogen. Clinical Infectious Diseases, 49, 124-131.
http://dx.doi.org/10.1086/599375
[13] Daly, K.A., Hoffman, H.J., Kvaerner, K.J., Casselbrant, M.L., Homoe, P. and Rovers, M.M. (2010) Epidemiology, Natural History, and Risk Factors: Panel Report from the Ninth International Research Conference on Otitis Media. International Journal of Pediatric Otorhinolaryngology, 74, 231-240.
http://dx.doi.org/10.1016/j.ijporl.2009.09.006
[14] Leibovitz, E., Broides, A., Greenberg, D. and Newman, N. (2010) Current Management of Pediatric Acute Otitis Media. Expert Review of Anti-Infective Therapy, 8, 151-161.
http://dx.doi.org/10.1586/eri.09.112
[15] Thornton, R.B., Wiertsema, S.P., Kirkham, L.A.S., Rigby, P.J., Vijayasekaran, S., Coates, H.L. and Richmond, P.C. (2013) Neutrophil Extracellular Traps and Bacterial Biofilms in Middle Ear Effusion of Children with Recurrent Acute Otitis Media—A Potential Treatment Target. PLoS ONE, 8, e53837. http://dx.doi.org/10.1371/journal.pone.0053837
[16] Pelton, S.I. and Leibovitz, E. (2009) Recent Advances in Otitis Media. Pediatric Infectious Disease Journal, 28, S133-S137.
http://dx.doi.org/10.1097/INF.0b013e3181b6d81a
[17] Parameswaran, G.I. and Murphy, T.F. (2009) Chronic Obstructive Pulmonary Disease. Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient. Drugs & Aging, 26, 985-995.
http://dx.doi.org/10.2165/11315700-000000000-00000
[18] Takahashi, M., Niwa, H. and Yanagita, N. (1990) PO2 Levels in Middle Ear Effusions and Middle Ear Mucosa. Acta Oto-Laryngologica, 110, 39-42.
http://dx.doi.org/10.3109/00016489009124807
[19] Kostova, M., Myers, C., Beck, T., Plotkin, B., Green, J., Boshoff, H., Barry III, C.E., Deschamps, J. and Konaklieva, M. (2011) C4-Alkylthiols with Activity against Moraxella catarrhalis and Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry, 19, 6842-6852.
http://dx.doi.org/10.1016/j.bmc.2011.09.030
[20] Brook, I. (2005) Microbiology and Antimicrobial Management of Sinusitis. Journal of Laryngology & Otology, 119, 251-258.
http://dx.doi.org/10.1258/0022215054020304
[21] Kirby, D., Raino, C., Rabor Jr., S.F., Wasson, C. and Plotkin, B. (2012) Semi-Automated Method for Multi-Tasking Measurement of Microbial Growth, Capsule, and Biofilm Formation. Advances in Microbiology, 2, 623-628.
http://dx.doi.org/10.4236/aim.2012.24081
[22] Wang, W., Kinkel, T., Martens-Habbena, W., Stahl, D.A., Fang, F.C. and Hansen, E.J. (2011) The Moraxella catarrhalis Nitric Oxide Reductase Is Essential for Nitric Oxide Detoxification. Journal of Bacteriology, 193, 2804-2813.
http://dx.doi.org/10.1128/JB.00139-11
[23] Wang, W., Reitzer, L., Rasko, D., Pearson, M., Blick, R., Laurence, C. and Hansen, E. (2007) Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected in Vitro Growth Conditions on Global Gene Expression. Infection and Immunity, 75, 4959-4971.
http://dx.doi.org/10.1128/IAI.00073-07
[24] Fux, C., Shirtliff, M., Stoodley, P. and Costerton, J. (2005) Can Laboratory Reference Strains Mirror “Real-World” Pathogenesis? Trends in Microbiology, 13, 58-63.
http://dx.doi.org/10.1016/j.tim.2004.11.001
[25] Brook, I. (2006) Bacteriology of Chronic Sinusitis and Acute Exacerbation of Chronic Sinusitis. JAMA Otolaryngology-Head & Neck Surgery, 132, 1099-1101.
http://dx.doi.org/10.1001/archotol.132.10.1099
[26] Hoban, D.J., Doern, G.V., Fluit, A.C., Roussel-Delvallez, M. and Jones, R.N. (2001) Worldwide Prevalence of Antimicrobial Resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases, 32, S81-S93.
http://dx.doi.org/10.1086/320181
[27] Manfredi, R., Nanetti, A., Valentini, R. and Chiodo, F. (2000) Moraxella catarrhalis Pneumonia during HIV Disease. Journal of Chemotherapy, 12, 406-411.
http://dx.doi.org/10.1179/joc.2000.12.5.406
[28] Marchisio, P., Ghisalberti, E., Fusi, M., Baggi, E., Ragazzi, M. and Dusi, E. (2007) Paranasal Sinuses and Middle Ear Infections: What Do They Have in Common? Pediatric Allergy and Immunology, 18, 31-34.
http://dx.doi.org/10.1111/j.1399-3038.2007.00630.x
[29] Falsetta, M., Steichen, C., McEwan, A., Cho, C., Ketterer, M., Shao, J., Hunt, J., Jennings, M. and Apicella, M. (2011) The Composition and Metabolic Phenotype of Neisseria gonorrhoeae Biofilms. Frontiers in Microbiology, 2, 75.
http://dx.doi.org/10.3389/fmicb.2011.00075
[30] Kofoed, M., Nielsen, D., Revsbech, N. and Schramm, A. (2012) Fluorescence in Situ Hybridization (FISH) Detection of Nitrite Reductase Transcripts (nirS mRNA) in Pseudomonas stutzeri Biofilms Relative to a Microscale Oxygen Gradient. Systematic and Applied Microbiology, 35, 513-517.
http://dx.doi.org/10.1016/j.syapm.2011.12.001
[31] John, E., Russell, P., Nam, B., Jinn, T. and Jung, T. (2001) Concentration of Nitric Oxide Metabolites in Middle Ear Effusion. International Journal of Pediatric Otorhinolaryngology, 60, 55-58.
http://dx.doi.org/10.1016/S0165-5876(01)00509-2
[32] Hamad, M., Austin, C., Stewart, A., Higgins, M., Vázquez-Torres, A. and Voskuil, M. (2011) Adaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy, 55, 3313-3323.
http://dx.doi.org/10.1128/AAC.00953-10
[33] Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. M07-A8. 2009.
[34] Hoopman, T.C., Liu, W., Joslin, S.N., Pybus, C., Sedillo, J.L., Labandeira-Rey, M., Laurence, C.A., Wang, W., Richardson, J.A., Bakaletz, L.O. and Hansen, E.J. (2012) Use of the Chinchilla Model for Nasopharyngeal Colonization to Study Gene Expression by Moraxella catarrhalis. Infection and Immunity, 80, 982-995.
http://dx.doi.org/10.1128/IAI.05918-11
[35] Pearson, M., Laurence, C., Guinn, S. and Hansen, E. (2006) Biofilm Formation by Moraxella catarrhalis in Vitro: Roles of the UspA1 Adhesin and the Hag Hemagglutinin. Infection and Immunity, 74, 1588-1596.
http://dx.doi.org/10.1128/IAI.74.3.1588-1596.2006